Takao Hiraki1, Tetsushi Kamegawa2, Takayuki Matsuno3, Jun Sakurai4, Toshiyuki Komaki5, Takuya Yamaguchi6, Koji Tomita5, Mayu Uka5, Yusuke Matsui5, Toshihiro Iguchi5, Hideo Gobara7, Susumu Kanazawa5. 1. Department of Radiology, Okayama University Medical School, 2-5-1 Shikatacho, Kitaku, Okayama, 700-8558, Japan. hiraki-t@cc.okayama-u.ac.jp. 2. Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, 3-1-1 Tsushimanaka, Kitaku, Okayama, 700-8530, Japan. 3. Graduate School of Natural Science and Technology, Okayama University, 3-1-1 Tsushimanaka, Kitaku, Okayama, 700-8530, Japan. 4. Center for Innovative Clinical Medicine, Okayama University Hospital, 2-5-1 Shikatacho, Kitaku, Okayama, 700-8558, Japan. 5. Department of Radiology, Okayama University Medical School, 2-5-1 Shikatacho, Kitaku, Okayama, 700-8558, Japan. 6. Division of Radiology, Medical Technology Department, Okayama University Hospital, 2-5-1 Shikatacho, Kitaku, Okayama, 700-8558, Japan. 7. Division of Medical Informatics, Okayama University Hospital, 2-5-1 Shikatacho, Kitaku, Okayama, 700-8558, Japan.
Abstract
INTRODUCTION: This was a prospective, first-in-human trial to evaluate the feasibility and safety of insertion of biopsy introducer needles with our robot during CT fluoroscopy-guided biopsy in humans. MATERIALS AND METHODS: Eligible patients were adults with a lesion ≥ 10 mm in an extremity or the trunk requiring pathological diagnosis with CT fluoroscopy-guided biopsy. Patients in whom at-risk structures were located within 10 mm of the scheduled needle tract were excluded. Ten patients (4 females and 6 males; mean [range] age, 72 [52-87] years) with lesions (mean [range] maximum diameter, 28 [14-52] mm) in the kidney (n = 4), lung (n = 3), mediastinum (n = 1), adrenal gland (n = 1), and muscle (n = 1) were enrolled. The biopsy procedure involved robotic insertion of a biopsy introducer needle followed by manual acquisition of specimens using a biopsy needle. The patients were followed up for 14 days. Feasibility was defined as the distance of ≤ 10 mm between needle tip after insertion and the nearest lesion edge on the CT fluoroscopic images. The safety of robotic insertion was evaluated on the basis of machine-related troubles and adverse events according to the Clavien-Dindo classification. RESULTS: Robotic insertion of the introducer needle was feasible in all patients, enabling pathological diagnosis. There was no machine-related trouble. A total of 11 adverse events occurred in 8 patients, including 10 grade I events and 1 grade IIIa event. CONCLUSION: Insertion of biopsy introducer needles with our robot was feasible at several locations in the human body. KEY POINTS: • Insertion of biopsy introducer needles with our robot during CT fluoroscopy-guided biopsy was feasible at several locations in the human body.
INTRODUCTION: This was a prospective, first-in-human trial to evaluate the feasibility and safety of insertion of biopsy introducer needles with our robot during CT fluoroscopy-guided biopsy in humans. MATERIALS AND METHODS: Eligible patients were adults with a lesion ≥ 10 mm in an extremity or the trunk requiring pathological diagnosis with CT fluoroscopy-guided biopsy. Patients in whom at-risk structures were located within 10 mm of the scheduled needle tract were excluded. Ten patients (4 females and 6 males; mean [range] age, 72 [52-87] years) with lesions (mean [range] maximum diameter, 28 [14-52] mm) in the kidney (n = 4), lung (n = 3), mediastinum (n = 1), adrenal gland (n = 1), and muscle (n = 1) were enrolled. The biopsy procedure involved robotic insertion of a biopsy introducer needle followed by manual acquisition of specimens using a biopsy needle. The patients were followed up for 14 days. Feasibility was defined as the distance of ≤ 10 mm between needle tip after insertion and the nearest lesion edge on the CT fluoroscopic images. The safety of robotic insertion was evaluated on the basis of machine-related troubles and adverse events according to the Clavien-Dindo classification. RESULTS: Robotic insertion of the introducer needle was feasible in all patients, enabling pathological diagnosis. There was no machine-related trouble. A total of 11 adverse events occurred in 8 patients, including 10 grade I events and 1 grade IIIa event. CONCLUSION: Insertion of biopsy introducer needles with our robot was feasible at several locations in the human body. KEY POINTS: • Insertion of biopsy introducer needles with our robot during CT fluoroscopy-guided biopsy was feasible at several locations in the human body.
Authors: Stephen B Solomon; Alexandru Patriciu; Mark E Bohlman; Louis R Kavoussi; Dan Stoianovici Journal: Radiology Date: 2002-10 Impact factor: 11.105
Authors: Martin Wiewiorski; Victor Valderrabano; Martin Kretzschmar; Helmut Rasch; Tanja Markus; Severine Dziergwa; Sebastian Kos; Deniz Bilecen; Augustinus Ludwig Jacob Journal: Minim Invasive Ther Allied Technol Date: 2009 Impact factor: 2.442
Authors: Ga Ram Kim; Jin Hur; Sang Min Lee; Hye-Jeong Lee; Yoo Jin Hong; Ji Eun Nam; Hua Sun Kim; Young Jin Kim; Byoung Wook Choi; Tae Hoon Kim; Kyu Ok Choe Journal: Eur Radiol Date: 2010-08-22 Impact factor: 5.315
Authors: Maximilian Neidhardt; Stefan Gerlach; Robin Mieling; Max-Heinrich Laves; Thorben Weib; Martin Gromniak; Antonia Fitzek; Dustin Mobius; Inga Kniep; Alexandra Ron; Julia Schadler; Axel Heinemann; Klaus Puschel; Benjamin Ondruschka; Alexander Schlaefer Journal: IEEE Trans Med Robot Bionics Date: 2022-01-26
Authors: Pascale Tinguely; Iwan Paolucci; Simeon J S Ruiter; Stefan Weber; Koert P de Jong; Daniel Candinas; Jacob Freedman; Jennie Engstrand Journal: Front Oncol Date: 2021-09-23 Impact factor: 6.244